BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Migraines Be Gone: AbbVie’s Atogepant Reduces Headache Frequency and Severity

  Migraine headaches can be reduced in frequency and severity by atogepant, an oral therapy developed by AbbVie. So migraines will be gone sooner than we think.

  June 3, 2021

   · 

  4 min read

   · 

  Gail Dutton
• 

  Bio NC

  Research Roundup: A Complete Human Genome Sequenced and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  June 3, 2021

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  White House Science Chief Wants to Nullify Next Pandemic Within 100 Days

  The nation’s top science adviser believes the country’s renewed enthusiasm for science may pave the way for plug-and-play vaccines that can nullify the next pandemic before it starts.

  June 3, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Career Advice

  Growing Your Emotional Intelligence At Workplace to Become an Effective Employee

  Do you know that growing emotional intelligence at workplace can be beneficial for career growth? If not, have a look at the article and learn some tips.

  June 3, 2021

   · 

  4 min read

   · 

  Hannah Harshman
• 

  Drug Development

  With Action Date Imminent, Biogen’s Aducanumab Invokes Hope and Skepticism

  Alzheimer’s patients and their families wait with hope that this will mean some offer of treatment, while physicians that treat Alzheimer’s patients are mulling the implications of the drug, often with hesitancy and skepticism.

  June 3, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  A New $550 Million Life Sciences Venture Capital Fund is in Town

  venBio Global Strategic Fund IV will invest primarily in drug companies focused on developing therapies for unmet medical needs.

  June 3, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Business

  BioSpace Movers & Shakers, June 4

  Biopharma and life sciences organizations strengthen their leadership teams and board with these Movers & Shakers.

  June 3, 2021

   · 

  9 min read

   · 

  Alex Keown
• 

  Business

  Merck Spinout Launches to Tackle Global Women’s Health Care Problems

  Organon’s focus will center on reproductive health, health conditions, and issues unique to women and diseases that disproportionately impact women.

  June 3, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  Drug Development

  Novartis Breaks Through with Radioligand Therapy for Prostate Cancer

  Today, the Swiss pharma titan announced the results of its Phase III VISION study, where 177Lu-PSMA-617 plus best standard of care (SOC) met both of its primary endpoints.

  June 3, 2021

   · 

  4 min read

   · 

  Heather McKenzie
• 

  Deals

  “SPAC King” Drops a Cool $800 Million to Launch an Array of Biotechs

  Venture capitalist Chamath Palihapitiya is raising $800 million to finance four more special purpose acquisition companies that will be focused on taking biotech companies public.

  June 3, 2021

   · 

  2 min read

   · 

  Alex Keown